Patient Square Capital LP
Q4 2025 13F Holdings
- Locationmenlo park, CA
- Num holdings
28
- Value ($000)
$467,132
- Date Filed02/12/2026
- Form type13F-HR
- CIK0001819257
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD | SHS | G76279101 | $177.2M | 38 % | 8,166,047 | ||
INSMED INC | COM PAR $.01 | 457669307 | $46.47M | 10 % | 267,000 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | $23.59M | 5 % | 298,682 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | $21.86M | 5 % | 26,000 | ||
BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | $21.06M | 5 % | 69,312 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $17.53M | 4 % | 130,000 | ||
PHARVARIS N V | COM | N69605108 | $15.06M | 3 % | 542,696 | ||
EYEPOINT INC | COM NEW | 30233G209 | $14.25M | 3 % | 780,000 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | $12.93M | 3 % | 320,000 | ||
CELCUITY INC | COM | 15102K100 | $11.97M | 3 % | 120,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100